2026 NPPES data Corneal and Contact Management Optometrist NPI 1922193242 O.D.
Verify on CMS →

FRANK AQUISTAPACE, O.D.

Corneal and Contact Management Optometrist in RUTLAND, Vermont. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
217
Medicare Part D claims · 57 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

FRANK AQUISTAPACE, O.D. filed 217 Medicare Part D claims in 2023 as a Corneal and Contact Management Optometrist in RUTLAND, Vermont, prescribing 77% generic.

217
Part D claims, 2023
77%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

FRANK AQUISTAPACE, O.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

217 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about FRANK AQUISTAPACE, O.D.?

Quality data not reported

NPI registry status

Active

Issued 10/03/2006

NPI 1922193242

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

217 8% vs specialty avg

2023 prescription claims

Specialty avg: 235

Specialty distribution in Vermont

How Corneal and Contact Management Optometrist compares to other specialties among Vermont providers

Vermont providers

Corneal and Contact Management Optometrist share within Vermont

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within Vermont

Specialty board-certification context

Estimated specialty board-certified rate — Corneal and Contact Management Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Corneal and Contact Management Optometrist ABMS/AOA estimate

Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Corneal and Contact Management Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

FRANK AQUISTAPACE, O.D. is a Corneal and Contact Management Optometrist provider practicing in RUTLAND, Vermont, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D.. NPI: 1922193242. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

FRANK AQUISTAPACE, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 62 WOODSTOCK AVE, RUTLAND, VT, 05701, with a listed phone of (802) 775-2660. NPI 1922193242 was issued on 10/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AQUISTAPACE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 217 prescription claims written by this provider, covering 57 Medicare beneficiaries and totaling roughly $32K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

62 WOODSTOCK AVE
RUTLAND, VT 05701

Provider Details

NPI 1922193242
Specialty Corneal and Contact Management Optometrist
Credentials O.D.
Gender Male
NPI Issued 10/03/2006

Hospital and facility affiliations

Facilities where FRANK AQUISTAPACE, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COMMUNITY HEALTH CENTERS OF THE RUTLAND REGION INC
RUTLAND, VT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

FRANK AQUISTAPACE, O.D. — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 217 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

217
Total Claims
$32K
Total Drug Cost
57
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
425
Total Day Supply
12,042
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$27K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
75.4 years
Avg HCC Risk Score
0.79
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
122
Timolol Maleate
17
Brimonidine Tartrate
16
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
16
Restasis
Cyclosporine
14
Lumigan
Bimatoprost
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How FRANK AQUISTAPACE, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

FRANK AQUISTAPACE, O.D.'s 217 claims are below the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in Vermont

Other clinicians with the same primary specialty enrolled in Vermont, drawn from the same CMS NPPES roster as AQUISTAPACE.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is FRANK AQUISTAPACE, O.D.'s specialty?
FRANK AQUISTAPACE, O.D. specializes in Corneal and Contact Management Optometrist and practices in RUTLAND, Vermont. Credentials: O.D..
How much does FRANK AQUISTAPACE, O.D. prescribe under Medicare Part D?
In 2023, FRANK AQUISTAPACE, O.D. wrote 217 Medicare Part D claims totaling $32K in drug costs for 57 beneficiaries.
Where is FRANK AQUISTAPACE, O.D. located?
FRANK AQUISTAPACE, O.D. is located at 62 WOODSTOCK AVE, RUTLAND, VT, 05701. Phone: (802) 775-2660.
What is FRANK AQUISTAPACE, O.D.'s NPI number?
FRANK AQUISTAPACE, O.D.'s National Provider Identifier (NPI) is 1922193242, issued on 10/03/2006.
Does FRANK AQUISTAPACE, O.D. prescribe more brand-name or generic drugs?
FRANK AQUISTAPACE, O.D.'s prescribing is 23% brand-name and 77% generic drugs by claim count, with $27K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does FRANK AQUISTAPACE, O.D. prescribe most often?
Based on 2023 Medicare Part D data, FRANK AQUISTAPACE, O.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does FRANK AQUISTAPACE, O.D. accept Medicare?
FRANK AQUISTAPACE, O.D. appears in CMS Medicare data with 217 Part D claims and 57 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify FRANK AQUISTAPACE, O.D.'s credentials?
FRANK AQUISTAPACE, O.D.'s NPI is 1922193242 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology